4//SEC Filing
Kewalramani Reshma 4
Accession 0000875320-25-000018
CIK 0000875320other
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 4:37 PM ET
Size
6.7 KB
Accession
0000875320-25-000018
Insider Transaction Report
Form 4
Kewalramani Reshma
DirectorCEO & President
Transactions
- Award
Common Stock
2025-02-04+29,118→ 104,890 total - Award
Common Stock
2025-02-04+20,328→ 125,218 total
Footnotes (2)
- [F1]Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2022 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/04/2025 and the shares will vest on 02/26/2025.
- [F2]Represents earned performance shares with respect to a performance stock unit award granted on 02/07/2024 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/04/2025 and the shares will vest in installments beginning on 02/17/2025.
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeother
Related Parties
1- filerCIK 0001735944
Filing Metadata
- Form type
- 4
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 4:37 PM ET
- Size
- 6.7 KB